Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-153213)
Article History
Received: 15 February 2022
Accepted: 7 October 2022
First Online: 2 December 2022
Declarations
:
: UBC Clinical Research Ethics Board
: N/A
: N/A
: Mohammad Ehsanul Karim has received consulting fees from Biogen, Inc., independent of this manuscript. All other authors declare no conflict of interest.